Thus, as also briefly discussed earlier, the CD27/70 pathway represents a good target to address AML; in fact, Riether et al., in in vitro studies, documented strong proliferation inhibition blocking CD27 and CD70 [138]. The gene discussed is CD70; the disease is acute myeloid leukemia.